



 The term “epigenetics” refers to heritable changes in gene expression not associated with 
alteration of DNA sequence. There is considerable research exploring how changes at the 
epigenetic level influence tumor progression. Preservation of tissue samples with the formalin 
fixed, paraffin embedded (FFPE) technique is commonly used to archive tumor biopsy samples. 
There is currently no method for extracting chromatin from FFPE tissue that is compatible with 
all downstream analysis techniques. We investigated if a cavitation enhancement reagent called 
“nanodroplets” employed during acoustic sonication would improve chromatin recovery and 
fragmentation from FFPE tissue. We assessed the quality of the chromatin extracted using 
Formaldehyde Assisted Isolation of Regulatory Elements (FAIRE), which separates nucleosome 
depleted or “open” chromatin from protein rich or “closed” chromatin. FAIRE requires high-
quality chromatin to achieve a significant open chromatin signal to background ratio by the 
quantitative polymerase chain reaction (qPCR) or high throughput sequencing (HTS). Ewing 
sarcoma cell lines and rodent xenograft tissue were used as a model system in our study because 
they contain a known, disease-specific aberrantly open chromatin signature. We performed 
FAIRE on rodent tumor xenograft tissue followed by qPCR and found that nanodroplets 
improved data consistency and significantly increased the FAIRE signal to background ratio at 
Ewing sarcoma-specific regions. Next, we will use HTS to determine if the genome-wide FFPE 
FAIRE signature is comparable to that from fresh/frozen tissue samples. If successful across a 
variety of tissue types, our protocol could be applied to chromatin signature-based cancer 
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 Epigenetic signatures such as DNA methylation and histone modification are important 
regulators of gene expression. The term epigenetics refers to changes in gene expression 
unrelated to modification of the actual gene sequence
1
. Chromatin consists of DNA wrapped 
around histone protein octamers (dimers of H3, H4, H2A and H2B), often described as being 
similar to “beads on a string
2
”. The functional unit of chromatin is the nucleosome, which 
consists of approximately 146 base pairs of DNA wound around the histone octamer and 
separated by a linker DNA-histone H1 unit
3
. Nucleosomes are a significant barrier to 
transcription because they block the progression of RNA polymerase II
4
. Genome wide 
nucleosome occupancy studies have demonstrated that nucleosomes are depleted at promoters 
associated with active transcription
5
. Cis acting DNA sequences and DNA binding proteins alter 
nucleosome stability
6
. Disruption of these mechanisms for nucleosome positioning can lead to 
the loss of gene regulation in vivo
7
.  This change in nucleosome positioning can be referred to as 
“chromatin signature”. Tumor cells have altered gene expression and therefore key changes in 
chromatin signature. Ewing sarcoma is an example of a cancer whose oncogenic effects result 
from disrupted nucleosome positioning. 
Chromatin accessibility 
 The propagation of regulatory elements along the genome is determined by “open” 
nucleosome depleted sites
8
. There are 3 assays for isolating accessible regions of the genome
9
. 
DNase1 hypersensitivity utilizes enzymatic digestion to cut nucleosome free regions of DNA, 
but is capable of producing cleavage bias
10
. ATAC-seq utilizes a hyperactive Tn5 transposase to 
fragment and identify regulatory elements
11
. ATAC-seq, like DNase 1, requires careful titration 
of enzyme concentration to avoid cleavage bias. Formaldehyde Assisted Isolation of Regulatory 
4 
 
Elements (FAIRE) is a chemical-based method for looking at a genome wide analysis of 
nucleosome depleted regions of open chromatin. Differences in the efficiency of crosslinking 
chromatin across the genome allows for the isolation of noncoding regions such as promoters 
that are accessible to RNA polymerase II, as first demonstrated in the yeast, Saccharomyces 
cerevisiae
12
. FAIRE has been optimized for use on Eukaryotic tissue
13
 and can extensively map 








Because it is a chemical-based method, FAIRE does not degrade the enriched nucleosome 
depleted active chromatin and is not affected by enzyme bias
14
. Conducting FAIRE followed by 
high throughput sequencing (FAIRE-seq) produces an overall view of active regulatory elements 
and is protein target independent. Isolating global euchromatic regions associated with higher 
levels of gene expression would enable the identification of disease specific loci, such as the 




 Ewing sarcoma tumor cells are characterized by an oncoprotein that results from a 
chromosomal translocation.  EWS-FLI1 is the most common type of translocation making up 
85% of Ewing sarcoma tumors, but there are other ETS fusions in Ewing sarcoma and other 
Figure 1. Overview of modified 
FAIRE treatment.  
We supplemented solid-phase 
column chromatography to 
separate open chromatin from 
crosslinked DNA, because 
performing organic phenol 






. The most common cancer causing EWS fusions are ERG, FLI1, and ETV1
17
. The 
EWSR1 gene product contains a transcription activation domain and an RNA binding domain
18
, 
whereas the ETS proteins are DNA binding transcription factors. Following chromosomal 
translocation, the activation domain of EWSR1 is fused to the DNA binding domain of the ETS 
protein to create the EWS-ETS oncoprotein
17
.  
 EWS-FLI1 alters downstream gene expression by binding to GGAA microsatellite repeat 
loci
19,20
. GGAA microsatellite binding subsequently increases expression of the EGR2 
transcription factor in Ewing sarcoma compared to normal tissue
15
. EGR2 silencing results in the 
inhibition of cell proliferation and tumor growth when conducted in vivo on Ewing sarcoma 
xenografts
21
. Ian Davis’ laboratory at UNC demonstrated that EWS-FLI1 binding results in 
nucleosome depletion at GGAA microsatellite repeats, while silencing EWS-FLI1 restores the 
nucleosomes in these regions, and halts cell proliferation
22
. Disease specific changes in 
nucleosome occupancy present an opportunity for both diagnostics and targeted therapy of this 
cancer. Diagnosing Ewing sarcoma can be done using fluorescence in situ hybridization (FISH) 
and RT-PCR on formalin fixed, paraffin embedded tissue. FISH uses DNA probes to test for the 
presence of a breakpoint in the EWSR1 gene. These assays are limited as they do not distinguish 
the fusion partner
23
 and require prior knowledge about the loci of interest.  
FFPE and Diagnostics  
 The FAIRE protocol takes advantage of the molecular changes involved in crosslinking 
DNA to histones using formaldehyde
12
. Formalin-Fixed, Paraffin Embedded (FFPE) tissue is a 
widely used method for preserving patient biopsy samples through formaldehyde crosslinking 
and dehydration
24
. FFPE samples can be stored at room temperature and there is an abundance of 
preexisting clinical archives
25
. While the nucleic acid sequence is maintained in FFPE tissue, the 
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quality of DNA may be reduced. The reduction in quality is a result of the DNA becoming 
fragmented and inadequate purification methods during the process
24
. Ensuing molecular 
analysis techniques, such as the polymerase chain reaction (PCR), is affected by the limited 
amount of purified DNA that can be obtained. Next generation sequencing is typically performed 
on DNA isolated from fresh or frozen tissue, but these clinical samples are limited in that they 
deteriorate quickly and are difficult to obtain
26
. We would like to utilize the availability and 
convenience of patient FFPE tissue samples for use in cancer diagnostics through the isolation 
and subsequent identification of specific epigenetic signatures. 
 Fragmentation is essential to the FAIRE protocol for isolating regulatory elements. 
Chromatin can be fragmented by mechanical disruption (sonication) or enzymatic digestion. 
Enzymatic digestion often uses micrococcal nuclease, which degrades chromatin with enzymes 
that digest the DNA between nucleosomes
27
. A major drawback to the use of enzymes is biased 
digestion that can lead to non-random fragmentation prior to sequencing
28
. Mechanical 
fragmentation of chromatin generally produces more random DNA fragments
29
, but is often 
inconsistent and time-consuming. Current sonication methods, such as the Covaris, use high 
intensity focused ultrasound in order to sheer samples in short bursts. A cavitation enhancing 
agent called nanodroplets (developed in Paul Dayton’s lab at UNC) when added in solution with 
DNA has been show to improve the consistency of a mechanical fragmentation in a low 
frequency bench top waterbath
30
. Nanodroplets are comprised of a liquid core made up of a 
stable perfluorocarbon and a single layered lipid membrane
31
. Cavitation is the expansion and 
contraction of a nanodroplet when induced by acoustic pressure. The energy released by 
cavitating nanodroplets when exposed to high frequency ultrasound waves will enhance DNA 
fragmentation
30
.  We call this process Reagent Assisted Cavitation Enhancement (RACE). 
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 We are interested in exploiting chromatin signature for diagnostics. Ewing sarcoma 
served as our model system for chromatin.  In order to achieve a broad spectrum analysis, we 
also had the opportunity to test uncrosslinked genomic DNA in cells. The Ramsey lab provided 
whole blood cells intended for a malaria diagnostic kit. These blood samples were used to 
explore the application of nanodroplets to low frequency sonication of DNA from intact cells. 
An optimized RACE protocol could then be applied to FFPE crosslinked chromatin that is more 
challenging to break apart and requires high frequency sonication. 
 We can use cavitation enhancement to isolate high-quality chromatin from FFPE tissue, 
which, for the first time, will make it possible to study changes in nucleosome occupancy in 
Ewing sarcoma associated with cancer in archived patient samples. By comparing the chromatin 
signatures through quantitative PCR (qPCR), we are able to test for the presence or absence of 
nucleosome depleted sites with nanodroplet treatment during sonication. Our study will then 
proceed to exploring different EWS-ETS fusions containing a chromosomal break other than 
EWS-FLI. Different DNA binding domains fused to the EWS activation domain may result in 
unique chromatin signatures whose presence can be identified utilizing FAIRE.   
 
Methods 
Low Frequency DNA Fragmentation. One hundred microliters (µL) of SDS/PAGE treated 
whole blood cells were sonicated in a Branson 2510 ultrasonic waterbath with 10 µl 
perfluorobutane nanodroplets or buffer saline. The water bath was set at a height of 67.7mm, 
temperature of 4°C, and centrally positioned in a floating plastic holder. DNA was extracted 
using Qiagen Blood and Tissue kit and resuspended in 200 µL volume. DNA concentration was 
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determined using Qubit fluorometer. Twenty µL of each DNA sample was run on a 1.3% 
agarose gel.  
Determining Cell Lysis Efficiency. EWS894 and EWS502 mouse xenografts were obtained by 
injecting approximately 10
6 
cells subcutaneously into a nude mouse. The tumor was allowed to 
grow for six weeks. The tumor was sectioned and placed into 10% formaldehyde in order to 
create an FFPE tissue block. MHH, SKES, REDES, and EWS502 FFPE patient derived cell 
pellets were sectioned into 10 micron (μm) slices and one section was placed per slide.  Slides 
were deparaffinized in xylene and rehydrated in decreasingly concentrated (100%, 85%, 70%, 
and 0%) ethanol solutions. Suspended tissue was sonicated in a Covaris Sonicator at 4°C (20% 
duty cycle; intensity = 8; and 200 cycles per burst) for 12 min. Lysates were centrifuged and the 
supernatant removed. DNA from both pellet and supernatant was extracted using Zymo Research 
ChIP DNA clean and concentrate kit (#D5201) according to manufacturer’s instructions. DNA 
concentration was determined using Qubit fluorometer.  
Standard FAIRE and qPCR. Tissue was isolated from EWS894 and EWS502 xenografts as 
described above and preserved by FFPE. FAIRE was performed after sonication. Solutions were 
cold room centrifuged and the pellet discarded. We transferred 10% of the supernatant from each 
tube to new 1.5mL Eppendorf tubes to serve as inputs. Input samples were digested with 
proteinase K overnight through incubation at 55⁰C. The remaining supernatant was purified 
using the Zymo Research ChIP DNA clean and concentrate kit, eluted as FAIRE DNA and 
stored overnight at 0⁰C. Both input and FAIRE samples were digested with RNase and then 
purified to a final volume of 25 µl. Relative nucleosome occupancy was determined using qPCR 
on FAIRE and input samples. AURKAIP1 and BC006361 primer sets served as positive and 
negative controls, while P1 and P7 are Ewing sarcoma specific regions of open chromatin.  Two 
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μL of DNA sample was pipetted into the wells of a 384-well plate, and then 8 μL of qPCR 
master mix  [2.8µl de-ionized water, 0.1µl of Primer 1, 0.1µl Primer 2, 5µl of 2 X SYBR green 
master mix (Roche)] was added.  PCR was run on a ViiA7 Real-Time PCR system (Applied 




Validation of RACE on Genomic DNA. We began our analysis by first optimizing the use of 
RACE on blood cells. RACE employs nanodroplets in order to enhance the number of cavitation 
events, in this case during low frequency 
sonication, increasing consistency of 
genomic DNA fragmentation for use in 
sequencing
30
. While low frequency 
sonication is suitable for blood cells, FFPE 
tissue requires a high frequency sonicator in 
order to disrupt crosslinking. Because 
chromatin fragmentation is essential to the 
FAIRE technique, we first evaluated the 
performance of RACE on fresh whole blood 
samples. A time titration was conducted 
using a Branson low frequency ultrasonic water bath, ranging from 4 to 6 minutes of sonication 
on intact blood cells. The whole blood cell solution contained either 10 µl of nanodroplets or 
phosphate buffered saline (PBS). Fragmented DNA was isolated at approximately 500 base pairs 
in length, the optimal range for use in high throughput sequencing, after six minutes of 
Figure 2. Fragmentation of DNA from intact blood cells using 
a Branson low frequency ultrasonic water bath. The amount 
of time the samples were sonicated and whether they 
contained nanodroplets varied.  
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sonicating with nanodroplets (Figure 2). There was minimal fragmentation without nanodroplets 
at 6 minutes.  
Application of FAIRE to FFPE Tissue.  Having looked at genomic DNA, we then proceeded 
to determining the impact of nanodroplets on isolating chromatin from FFPE tissue. RACE was 
adapted to our analysis of chromatin isolation by performing FAIRE and qPCR on EWS894 
rodent xenograft FFPE tissue. FFPE xenografts derived from nude mice provide a uniform tissue 
with known biomolecular markers, in this case originating from a Ewing sarcoma cell line. The 
rehydration method for FFPE tissue was modified here to utilize slides rather than tissue scrolls, 
which provided a reliable method for isolating tissue pellets. The modified protocol reduced the 
risk of sample loss due to pipetting error and sped up the rehydration process. Predetermined 
primers not specific to Ewing sarcomas were used correlating to open chromatin (AURKAIP1) 
or closed chromatin (BC00361). P1 and P7 are Ewing sarcoma specific microsatellite repeat 
regions that have aberrantly open chromatin signatures. RACE treatment during sonication of 
FFPE pellets increased the percent input signal at determined by qPCR at 3 of the 4 regions 
compared to RACE negative samples (Figure 3A). These samples are currently being sequenced 
to compare nanodroplet-isolated FFPE FAIRE samples to those from fresh tissues. 
 We conducted the same FAIRE qPCR procedure on EWS502 xenograft cell lines (Figure 
3B). The EWS502 tissue was more challenging for FAIRE as 0.06 ± 0.03 ng/µl of FAIRE DNA 
was released per individual slide compared to the 12.8 ± 1.35 ng/µl FAIRE DNA released from 
EWS894 tissue using RACE. The use of RACE on EWS502 did not have a significant difference 




Figure 3. FAIRE-qPCR after RACE treatment improved signal over background noise of some rodent xenograft tissue. 
AURKAIP1 is a region of chromatin that is always open, BC006361 is a region of chromatin that is always closed, ES1 and ES2 
are Ewing sarcoma disease-specific regions of aberrantly open chromatin.  The percent input is a ratio of the qPCR signal 
from DNA isolated from open chromatin to the total DNA. (A) Percent input is enriched at P1 and P7 for FFPE EWS894 rodent 
xenograft tissue. Error bars are the SD of 3 replicates. P values were calculated using a student’s T-test. (B) No enrichment 
after RACE treatment for FFPE EWS502 xenograft tissue; this is likely due to the difficulty of working with these xenografts as 































































































 Our investigation into the presence of chromatin signatures in ETS family translocations 
began with 4 samples containing similar EWS-FLI1 fusions: MHH, SKES, RDES, and EWS502.  
Prior to performing FAIRE, we evaluated the percent yield of fragmented DNA that can be 
isolated from these FFPE patient derived cell pellets. RACE was shown to significantly improve 
the recovery of fragmented chromatin for SKES, and EWS502 cell pellets when sonicated for 12 
minutes (Figure 4). For EWS502 cell pellets, RACE negative samples had 31.2 ± 5% of DNA 
found in the supernatant relative to the cell pellet. RACE positive samples containing 10 µl of 
nanodroplets prior to sonication were found to have more fragmented DNA in the supernatant 
than pellet. We are in the process of conducting FAIRE and qPCR on these various EWS fusion 
samples in order to identify the presence of aberrantly open chromatin at the P1 and P7 Ewing 
sarcoma-specific 
regions. These 
results will be 
compared to the 
EWS502 samples to 
determine if these 




sequencing of these 
samples will ensure 
Figure 4. Cell lysis efficiency for various ETS-Fusion FFPE cell pellets was improved by RACE. DNA 
recovery ratio was measured by the percent recovery of chromatin free in the supernatant 
compared to the tissue pellet after sonication.  Error bars represent the standard deviation of 3 
replicates.  P-values were calculated using the Student’s T-Test.  
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that FAIRE does not disrupt open chromatin. Sequencing will also verify that molecular analysis 
of FFPE tissue is comparable to fresh and frozen tissue. Human bladder tissue will serve as a 
control as it lacks the Ewing sarcoma specific open chromatin.   
 
Discussion 
 In contrast to utilizing fresh or frozen tissue in cancer based diagnostic screening, FAIRE 
offers an alternative use of FFPE tissue through the isolation of regulatory elements associated 
with gene regulation. The identification of a specific chromatin signature through qPCR 
demonstrates the effectiveness of FAIRE at functioning as a screen for changes in chromosomal 
accessibility. FAIRE does not depend on the enzymatic digestion step found in other chromatin 
accessibility techniques, such as DNase I or ATAC, and subsequently eliminates the possibility 
of enzyme bias. We will proceed with further sequencing of the FAIRE enriched FFPE EWS894 
xenograft DNA to determine if FAIRE disrupts aberrant chromatin assembly.  
 The employment of biologically inert cavitation enhancing nanodroplets has the potential 
to streamline the effectiveness of the FAIRE protocol by facilitating FFPE tissue dissociation.  A 
lack of nanodroplets during sonication generally resulted in a lower yield of FAIRE DNA, and 
we showed several examples where RACE was able to overcome the difficulties associated with 
obtaining high quality chromatin from FFPE tissue
33
. The ability to manufacture stable, size 
controlled nanodroplets for use in biological applications makes these agents potentially readily 
accessible for research and clinical applications
34
. While RACE improved the percent input 
during qPCR for EWS894 xenografts, there was not a clear distinguishable FAIRE signal with 
EWS502 xenografts. This is likely due to low chromatin yields from an individual FFPE 
14 
 
xenograft and combining multiple tissue slices prior to qPCR may improve the detection of 
FAIRE signatures and reveal a difference in RACE samples.  
 Mutations in chromatin modifiers or their co-factors that disrupt either the nucleosome 
contacts with DNA or nucleosome associated proteins are recognized events in a variety of 
cancers
3536
. The EWS-FLI1 fusion in Ewing sarcoma is well studied, however it remains 
unknown if various other tumors containing different EWS fusion oncoproteins have similar or 
different FAIRE signatures. Our modified FAIRE protocol has applications for any cellular 
change that is associated with chromatin accessibility. 
 In conclusion, we have developed a novel protocol that isolates regions of open 
chromatin that are accessible for gene expression from FFPE tissue. There have been challenges 
associated with isolating high quality DNA when performing FAIRE on FFPE tissue. 
Nanodroplet-mediated RACE improves the extraction of chromatin from FFPE tissue and 
enables us to study nucleosome-depleted sites in cancer regulatory pathways. Ewing sarcoma 
was used as a model system in our study, since it has known disease-specific regions of open 
chromatin. We will use that model system to identify key regulatory elements in tumor tissue 
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